BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38583735)

  • 1. Effect of traditional Chinese medicine on metabolism disturbance in ischemic heart diseases.
    Wang A; Song Q; Li Y; Fang H; Ma X; Li Y; Wei B; Pan C
    J Ethnopharmacol; 2024 Jul; 329():118143. PubMed ID: 38583735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.
    Jin X; Dong W; Chang K; Yan Y
    J Ethnopharmacol; 2024 May; 326():117850. PubMed ID: 38331124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine.
    Yang HY; Liu ML; Luo P; Yao XS; Zhou H
    Phytomedicine; 2022 Sep; 104():154268. PubMed ID: 35777118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Chinese herbal medicines in ischemic heart diseases (IHD) by regulating oxidative stress.
    Wang D; Wang J; Liu Y; Zhao Z; Liu Q
    Int J Cardiol; 2016 Oct; 220():314-9. PubMed ID: 27390948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
    Li Y; Ji X; Wu H; Li X; Zhang H; Tang D
    J Ethnopharmacol; 2021 Oct; 278():114207. PubMed ID: 34000365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study.
    Hung YC; Tseng YJ; Hu WL; Chen HJ; Li TC; Tsai PY; Chen HP; Huang MH; Su FY
    PLoS One; 2015; 10(8):e0137058. PubMed ID: 26322893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis.
    Bu L; Dai O; Zhou F; Liu F; Chen JF; Peng C; Xiong L
    Biomed Pharmacother; 2020 Dec; 132():110855. PubMed ID: 33059257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Patterns of Traditional Chinese Medicine for Ischemic Heart Disease Treatment: A Population-Based Cohort Study.
    Wang LS; Yen PT; Weng SF; Hsu JH; Yeh JL
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888597
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease.
    Xu F; Zhang H; Chen J; Zhan J; Liu P; Liu W; Qi S; Mu Y
    J Ethnopharmacol; 2024 Mar; 321():117514. PubMed ID: 38042388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional effects and mechanisms of traditional Chinese medicine.
    Peng X; Tang F; Yang Y; Li T; Hu X; Li S; Wu W; He K
    J Ethnopharmacol; 2022 Nov; 298():115578. PubMed ID: 35917892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy.
    Wang S; Fu JL; Hao HF; Jiao YN; Li PP; Han SY
    Pharmacol Res; 2021 Aug; 170():105728. PubMed ID: 34119622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms.
    Li X; Li L; Lei W; Chua HZ; Li Z; Huang X; Wang Q; Li N; Zhang H
    Biomed Pharmacother; 2021 Oct; 142():111979. PubMed ID: 34358754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.
    Xu M; Zhang D; Yan J
    Phytomedicine; 2024 Jul; 130():155738. PubMed ID: 38824825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms.
    Zhao Q; Bai J; Chen Y; Liu X; Zhao S; Ling G; Jia S; Zhai F; Xiang R
    J Ethnopharmacol; 2022 Oct; 297():115567. PubMed ID: 35870684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms.
    Lü S; Wang Q; Li G; Sun S; Guo Y; Kuang H
    J Ethnopharmacol; 2015 Dec; 176():177-206. PubMed ID: 26471289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the protective effects of Danqi Tongmai tablet on acute myocardial ischemia rats by comprehensive metabolomics profiling.
    Li Z; Hou J; Deng Y; Zhi H; Wu W; Yan B; Chen T; Tu J; Zhu Z; Wu W; Guo DA
    Phytomedicine; 2020 Aug; 74():152918. PubMed ID: 30979691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Therapeutic Mechanism of Traditional Chinese Medicine on Diabetes in Rodents: A Review from an NMR-Based Metabolomics Perspective.
    Huang Y; Lu J; Zhao Q; Chen J; Dong W; Lin M; Zheng H
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational and functional study elicits the ameliorating effect of the Chinese herbal formula Huo Luo Xiao Ling Dan on experimental ischemia-induced myocardial injury in rats via inhibition of apoptosis.
    Han XD; Zhou ZW; Yang W; Ye HC; Xu YZ; Huang YF; Zhang T; Zhou SF
    Drug Des Devel Ther; 2015; 9():1063-102. PubMed ID: 25733819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal regulatory roles of traditional Chinese medicine in ischemic stroke via inhibition of NLRP3 inflammasome.
    Tao YW; Yang L; Chen SY; Zhang Y; Zeng Y; Wu JS; Meng XL
    J Ethnopharmacol; 2022 Aug; 294():115316. PubMed ID: 35513214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.